留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

R-way阴道镜诊断系统在宫颈疾病诊断中的应用价值

王立群 何玉 李旭 杨康 朱宏 王亚飞

王立群, 何玉, 李旭, 杨康, 朱宏, 王亚飞. R-way阴道镜诊断系统在宫颈疾病诊断中的应用价值[J]. 中华全科医学, 2022, 20(10): 1704-1707. doi: 10.16766/j.cnki.issn.1674-4152.002684
引用本文: 王立群, 何玉, 李旭, 杨康, 朱宏, 王亚飞. R-way阴道镜诊断系统在宫颈疾病诊断中的应用价值[J]. 中华全科医学, 2022, 20(10): 1704-1707. doi: 10.16766/j.cnki.issn.1674-4152.002684
WANG Li-qun, HE Yu, LI Xu, YANG Kang, ZHU Hong, WANG Ya-fei. Clinical application value of R-way colposcopy diagnosis system in diagnosing cervical diseases[J]. Chinese Journal of General Practice, 2022, 20(10): 1704-1707. doi: 10.16766/j.cnki.issn.1674-4152.002684
Citation: WANG Li-qun, HE Yu, LI Xu, YANG Kang, ZHU Hong, WANG Ya-fei. Clinical application value of R-way colposcopy diagnosis system in diagnosing cervical diseases[J]. Chinese Journal of General Practice, 2022, 20(10): 1704-1707. doi: 10.16766/j.cnki.issn.1674-4152.002684

R-way阴道镜诊断系统在宫颈疾病诊断中的应用价值

doi: 10.16766/j.cnki.issn.1674-4152.002684
基金项目: 

安徽省教育厅重点项目 KJ2019A0343

蚌埠医学院2019年自然科学重点项目 BYKY2019 119ZD

详细信息
    通讯作者:

    何玉, E-mail: 1204675442@qq.com

  • 中图分类号: R711.74

Clinical application value of R-way colposcopy diagnosis system in diagnosing cervical diseases

  • 摘要:   目的  评估R-way阴道镜诊断系统在宫颈疾病诊断中的临床应用价值。  方法  2018年1—12月在蚌埠医学院第一附属医院阴道镜门诊就诊的患者中,选取保留有完整图像及病理随访结果的380例患者,应用R-way阴道镜诊断系统对图像进行回顾性分析并给出诊断结果,以宫颈组织病理诊断为“金标准”,比较R-way诊断系统与2011版阴道镜诊断术语对宫颈病变诊断的敏感度、特异度、约登指数及一致性,并计算ROC曲线下面积,评估R-way诊断系统在宫颈疾病诊断方面的临床应用价值。  结果  R-way系统诊断宫颈癌的灵敏度为62.9%,特异度为100.0%,约登指数为69.2%,符合率为98.9%;诊断宫颈高级别上皮内病变的灵敏度为84.9%,特异度为89.5%,约登指数为74.5%,符合率为88.4%;诊断宫颈低级别上皮内病变的灵敏度为76.1%,特异度为79.0%,约登指数为55.1%,符合率为78.2%。设定宫颈高级别以上病变为阳性组,低级别以下病变为阴性组;R-way诊断系统诊断宫颈阳性病变的灵敏度为86.8%,特异度为90.5%;2011版阴道镜诊断术语诊断宫颈阳性病变的灵敏度为73.6%,特异度为90.9%;两者诊断宫颈阳性病变的ROC曲线下面积分别为0.887、0.822。  结论  R-way诊断系统是一种简单易学、稳定有效的客观评价阴道镜图像的诊断系统,具有较高的临床应用和推广价值。

     

  • 图  1  R-way阴道镜图像

    注:A为红区,B为白区,C为黄区,D为A结构。

    Figure  1.  R-way colposcope image

    图  2  R-way诊断系统与2011阴道镜诊断术语诊断宫颈阳性病变的ROC曲线

    Figure  2.  ROC curve of R-way diagnostic system and 2011 colposcopy diagnostic terminology for diagnosing cervical positive lesions

    表  1  R-way诊断系统与阴道镜诊断术语评价指标(%)

    Table  1.   Comparison of R-way diagnostic system and colposcopy diagnostic value

    项目 检查方法 灵敏度(95% CI) 特异度(95% CI) 阳性预测值(95% CI) 阴性预测值(95% CI) 约登指数 符合率
    R-way 69.2(44.1~94.3) 100.0(100.0~100.0) 100.0(100.0~100.0) 98.9(97.9~100.0) 69.2 98.9
    阴道镜 61.5(35.1~88.0) 99.7(99.2~100.3) 88.9(68.4~109.4) 98.7(97.5~99.8) 61.3 98.4
    HSIL R-way 84.9(77.7~92.2) 89.5(86.0~93.1) 72.5(64.1~80.9) 94.8(92.2~97.5) 74.5 88.4
    阴道镜 68.8(59.4~78.2) 89.5(86.0~93.1) 68.1(58.7~77.5) 89.9(86.4~93.4) 58.4 84.5
    LSIL R-way 76.1(68.2~84.0) 79.0(74.1~83.9) 60.6(52.5~68.6) 88.7(84.6~92.7) 55.1 78.2
    阴道镜 72.6(64.3~80.8) 76.0(70.9~81.2) 56.2(48.1~64.2) 86.8(82.4~91.1) 48.6 75.0
    下载: 导出CSV

    表  2  R-way诊断系统及阴道镜诊断价值比较

    Table  2.   Comparison of R-way diagnostic system and colposcopy diagnostic value

    检查方法 真阳性
    (例)
    假阳性
    (例)
    真阴性
    (例)
    假阴性
    (例)
    灵敏度
    (95% CI, %)
    特异度
    (95% CI, %)
    阳性预测值
    (95% CI, %)
    阴性预测值
    (95% CI, %)
    约登指数
    (%)
    符合率
    (%)
    ROC曲线下面积
    (95% CI)
    R-way诊断系统 92 26 248 14 86.8(80.3~93.2) 90.5(87.0~94.0) 78.0(70.5~85.4) 94.7(91.9~97.4) 77.3 89.5 0.887±0.022(0.844~0.929)
    阴道镜诊断术语 78 25 249 28 73.6(65.2~82.0) 90.9(87.5~94.3) 75.7(67.4~84.0) 89.9(86.3~93.4) 64.5 86.1 0.822±0.027(0.769~0.876)
    下载: 导出CSV
  • [1] JOHNSON C A, JAMES D, MARZAN A, et al. Cervical cancer: An overview of pathophysiology and management[J]. Semin Oncol Nurs, 2019, 35(2): 166-174. doi: 10.1016/j.soncn.2019.02.003
    [2] 钱德英. 阴道镜下异常图像对宫颈病变筛查意义[J]. 中国实用妇科与产科杂志, 2016, 32(5): 399-402. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201605006.htm

    QIAN D Y. Significance of abnormal images under colposcopy in screening cervical lesions[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2016, 32(5): 399-402. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201605006.htm
    [3] FERLAY J, COLOMBET M, SOERJOMATARAM I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer, 2019, 144(8): 1941-1953. doi: 10.1002/ijc.31937
    [4] 刘萍. 中国大陆13年宫颈癌临床流行病学大数据评价[J]. 中国实用妇科与产科杂志, 2018, 34(1): 41-45. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201801014.htm

    LIU P. Evaluation of big data of clinical epidemiology of cervical cancer in Chinese Mainland in the past 13 years[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2018, 34(1): 41-45. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201801014.htm
    [5] SIMMS K T, STEINBERG J, CARUANA M, et al. Impact of scaled up human papilloma virus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: A modelling study[J]. Lancet Oncol, 2019, 20(3): 394-407. doi: 10.1016/S1470-2045(18)30836-2
    [6] 陈春林. 中国宫颈癌临床诊疗与大数据[J]. 中国实用妇科与产科杂志, 2018, 34(1): 25-29. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201801008.htm

    CHENG C L. Clinical diagnosis, treatment and big data of cervical cancer in China[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2018, 34(1): 25-29. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201801008.htm
    [7] SHANMUGASUNDARAM S, YOU J. Targeting persistent human papillomavirus infection[J]. Viruses, 2017, 9(8): 229. doi: 10.3390/v9080229
    [8] 徐军娟, 裘雅芬, 冯燕. 高危型人乳头瘤病毒对不同程度宫颈病变发生、发展及预后的影响研究[J]. 中华全科医学, 2016, 14(6): 1050-1052. doi: 10.16766/j.cnki.issn.1674-4152.2016.06.055

    XU J J, QIU Y F, FENG Y. Study on the influence of high-risk human papillomavirus on the occurrence, development and prognosis of different degrees of cervical lesions[J]. Chinese Journal of General Practice, 2016, 14(6): 1050-1052. doi: 10.16766/j.cnki.issn.1674-4152.2016.06.055
    [9] 倪昌雪, 王艳, 叶国柳, 等. HPV E6/E7 mRNA检查对宫颈细胞学ASCUS的分流价值[J]. 中华全科医学, 2021, 19(2): 198-201, 255. doi: 10.16766/j.cnki.issn.1674-4152.001766

    NI C X, WANG Y, YE G L, et al. The shunt value of HPV E6/E7 mRNA examination in cervical cytology ASCUS[J]. Chinese Journal of General Practice, 2021, 19(2): 198-201, 255. doi: 10.16766/j.cnki.issn.1674-4152.001766
    [10] 冯慧, 马德勇, 王婷婷, 等. TTR-way在宫颈癌筛查及阴道镜诊断培训中的价值研究[J]. 中国实用妇科与产科杂志, 2017, 33(3): 301-306. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201703020.htm

    FENG H, MA D Y, WANG T T, et al. Value of TTR-way in the training of cervical cancer screening and colposcopy diagnosis[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2017, 33(3): 301-306. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201703020.htm
    [11] CHEN W Q, ZHENG R S, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
    [12] 陈飞, 李舒, 胡惠英, 等. 2017年美国阴道镜和子宫颈病理学会阴道镜检查标准解读[J]. 中国实用妇科与产科杂志, 2018, 34(4): 413-418. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201804021.htm

    CHEN F, LI S, HU H Y, et al. Interpretation of colposcopy examination standard of American Society of colposcopy and cervical pathology in 2017[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2018, 34(4): 413-418. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201804021.htm
    [13] 魏玮, 臧茂娟, 陈国庆. 542例阴道镜图像特点及病理结果分析[J]. 中国妇幼保健, 2018, 33(6): 1221-1223. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201806008.htm

    WEI W, ZANG M J, CHENG G Q. Analysis on colposcopic image characteristics and pathological results in 542 cases[J]. Maternal and Child Health Care of China, 2018, 33(6): 1221-1223. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201806008.htm
    [14] MORA ENRIQUEZ J A, AMAYA GUIO J, SALAMANCA MORA S, et al. Evaluation of inter observer concordance of the Swede score for digital colposcopic images[J]. Rev Colomb Obstet Ginecol, 2019, 70(2): 94-102.
    [15] 潘云青. 人乳头状瘤病毒分型联合液基薄层细胞学检查、阴道镜Reid评分对宫颈上皮内瘤变分级诊断效能分析[J]. 中国现代医药杂志, 2021, 23(3): 95-98. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHTY202103039.htm

    PAN Y Q. Analysis of diagnostic efficacy of HPV typing combined with liquid-based thin-layer cytology and colposcopy Reid score in grading cervical intraepithelial neoplasia[J]. Modern Medicine Journal of China, 2021, 23(3): 95-98. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHTY202103039.htm
    [16] 邢亚萍, 宋晓霞. HR-HPV在宫颈癌中的分布特点及其与发病年龄的关系[J]. 医药论坛杂志, 2021, 42(13): 75-78. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYX202113020.htm

    XING Y P, SONG X X. Distribution characteristics of HR-HPV in cervical squamous carcinoma and its relationship with age of onset[J]. Journal of Medical Forum, 2021, 42(13): 75-78. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYX202113020.htm
    [17] 吴言, 王军. 临床阴道镜评分体系诊断宫颈鳞状上皮内病变的临床意义[J]. 中国社区医师, 2020, 36(20): 105-106. https://www.cnki.com.cn/Article/CJFDTOTAL-XCYS202020059.htm

    WU Y, WANG J. Study on the clinical significance of clinical colposcopy scoring system in diagnosis of cervical squamous intraepithelial lesions[J]. Chinese Community Doctors, 2020, 36(20): 105-106. https://www.cnki.com.cn/Article/CJFDTOTAL-XCYS202020059.htm
    [18] KUSHWAH S, KUSHWAH B. Correlation of two colposcopic indices for predicting premalignant lesions of cervix[J]. J Mid-life Health, 2017, 8(3): 118-123.
    [19] RANGA R, RAI S, KUMARI A, et al. A comparison of the strength of association of Reid colposcopic index and Swede score with cervical histology[J]. J Low Genit Tract Dis, 2017, 21(1): 55-58.
    [20] 刘芳, 张玉芳, 韩菁, 等. R-way系统对宫颈病变的诊断价值及影响因素分析[J]. 浙江医学, 2020, 42(11): 1117-1121. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJYE202011007.htm

    LIU F, ZHANG Y F, HAN J, et al. Diagnostic value and influencing factors of R-way system for cervical lesions[J]. Zhejiang Medical Journal, 2020, 42(11): 1117-1121. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJYE202011007.htm
  • 加载中
图(2) / 表(2)
计量
  • 文章访问数:  170
  • HTML全文浏览量:  115
  • PDF下载量:  1
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-09-30
  • 网络出版日期:  2022-11-30

目录

    /

    返回文章
    返回